DavidShibataMD
General Surgery • Memphis, TNSurgical Oncology (Other than Breast)
Associate Professor of Surgery, University S Fla College of Medicine
Are you Dr. Shibata?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1211 Union Ave
Ste 300
Memphis, TN 38104Phone+1 901-609-3520Fax+1 901-266-6415
Summary
- Dr. David Shibata, MD is a general surgeon in Memphis, Tennessee. He is currently licensed to practice medicine in Tennessee, Florida, and Maryland. He is an Associate Professor of Surgery at University S Fla College of Medicine.
Education & Training
McGill University Faculty of MedicineClass of 1991
Certifications & Licensure
TN State Medical License 2015 - 2026
FL State Medical License 2004 - 2017
MD State Medical License 2000 - 2005
American Board of Surgery Surgery
Publications & Presentations
PubMed
- Sedentary behavior and physical activity one year after colorectal cancer diagnosis: results from the ColoCare Study.Richard H Viskochil, Tengda Lin, Biljana Gigic, Caroline Himbert, Victoria M Bandera
Journal of Cancer Survivorship. 2025-02-22 - 3 citationsCirculating tryptophan-kynurenine pathway metabolites are associated with all-cause mortality among patients with stage I-III colorectal cancer.Victoria Damerell, Niels Klaassen-Dekker, Stefanie Brezina, Jennifer Ose, Arve Ulvik
International Journal of Cancer. 2025-02-01 - The gut microbiome is associated with disease-free survival in stage I-III colorectal cancer patients.Doratha A Byrd, Victoria Damerell, Maria F Gomez Morales, Stephanie R Hogue, Tengda Lin
International Journal of Cancer. 2025-01-31
Press Mentions
Health Care Heroes 2022: David Shibata of UTHSCDecember 7th, 2022- Chadwick Boseman’s Death from Colon Cancer Is ‘Eye-Opening,’ Doctors SayAugust 31st, 2020
Saving Lives Depends on Getting Jump on Colon CancerMarch 20th, 2010- Join now to see all
Grant Support
- Body composition and adiposity-associated thromboinflammation in colorectal cancer prognosisH. LEE MOFFITT CANCER CTR & RES INST2024–2028
- Body composition and adiposity-associated thromboinflammation in colorectal cancer prognosisH. LEE MOFFITT CANCER CTR & RES INST2024–2028
- Body composition and adiposity-associated thromboinflammation in colorectal cancer prognosisH. LEE MOFFITT CANCER CTR & RES INST2024–2028
- Body composition and adiposity-associated thromboinflammation in colorectal cancer prognosisH. LEE MOFFITT CANCER CTR & RES INST2024–2028
- Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare StudyUNIVERSITY OF UTAH2016–2026
- Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare StudyUNIVERSITY OF UTAH2016–2026
- Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare StudyUNIVERSITY OF UTAH2016–2026
- Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare StudyUNIVERSITY OF UTAH2016–2026
